Gender differences in antidepressant drug response (Q37806757)

23 August 2017

Gender differences in antidepressant drug response (English)

1 reference

23 August 2017

1

0 references

Katherine J. Aitchison

series ordinal

2

0 references

publication date

1 January 2010

1 reference

International Review of Psychiatry

23 August 2017

1 reference

23 August 2017

22

1 reference

23 August 2017

5

1 reference

23 August 2017

485-500

1 reference

Effect of chronic citalopram on serotonin-related and stress-regulated genes in the dorsal raphe nucleus of the rat.

23 August 2017

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2010.496448

Use of selective serotonin-reuptake inhibitors in pregnancy and the risk of birth defects

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2010.496448

Toward validation of atypical depression in the community: results of the Zurich cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2010.496448

Multi-dimensional criteria for the diagnosis of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2010.496448

Gender differences in treatment response to sertraline versus imipramine in patients with nonmelancholic depressive disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2010.496448

Inhibition of rat liver tryptophan pyrrolase activity and elevation of brain tryptophan concentration by administration of antidepressants

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2010.496448

Fluoxetine-induced up-regulation of 14-3-3zeta and tryptophan hydroxylase levels in RBL-2H3 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2010.496448

Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for Psychopharmacology

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2010.496448

Paroxetine and congenital malformations: meta-Analysis and consideration of potential confounding factors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2010.496448

Intestinal MDR transport proteins and P-450 enzymes as barriers to oral drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2010.496448

Sex differences in depression: a role for preexisting anxiety

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2010.496448

Gender differences among patients with a single depressive episode.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2010.496448

Comparing age at onset of major depression and other psychiatric disorders by birth cohorts in five US community populations

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2010.496448

Weight gain in infants breastfed by mothers who take fluoxetine.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2010.496448

Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2010.496448

Growth hormone determines sexual dimorphism of hepatic cytochrome P450 3A4 expression in transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2010.496448

Relapse of major depression during pregnancy in women who maintain or discontinue antidepressant treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2010.496448

Predicting age at menopause.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2010.496448

Steady-state plasma levels of nortriptyline and its 10-hydroxy metabolite: relationship to the CYP2D6 genotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2010.496448

Achieving remission with venlafaxine and fluoxetine in major depression: its relationship to anxiety symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2010.496448

Risks of congenital malformations and perinatal events among infants exposed to antidepressant medications during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2010.496448

Risk factors for 12-month comorbidity of mood, anxiety, and substance use disorders: findings from the Netherlands Mental Health Survey and Incidence Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2010.496448

Tricyclic antidepressants: long-term treatment increases responsivity of rat forebrain neurons to serotonin.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2010.496448

Paroxetine and fluoxetine in pregnancy: a prospective, multicentre, controlled, observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2010.496448

Use of psychotropic medications in treating mood disorders during lactation : practical recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2010.496448

Newer antidepressants in pregnancy and rates of major malformations: a meta-analysis of prospective comparative studies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2010.496448

Influence of P-glycoprotein inhibition on the distribution of the tricyclic antidepressant nortriptyline over the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2010.496448

Difference in treatment outcome in outpatients with anxious versus nonanxious depression: a STAR*D report.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2010.496448

Major depressive subtypes and treatment response.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2010.496448

Androgen actions on central serotonin neurotransmission: relevance for mood, mental state and memory.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2010.496448

Hormones and menopausal status as predictors of depression in women in transition to menopause

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2010.496448

Measurement of CYP2D6 and CYP3A4 activity in vivo with dextromethorphan: sources of variability and predictors of adverse effects in 419 healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2010.496448

The effect of postpartum depression on child cognitive development and behavior: a review and critical analysis of the literature.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2010.496448

Oral contraceptives containing ethinyl estradiol and gestodene markedly increase plasma concentrations and effects of tizanidine by inhibiting cytochrome P450 1A2.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2010.496448

Gender has a small but statistically significant effect on clearance of CYP3A substrate drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2010.496448

Estrogen receptor-beta regulates tryptophan hydroxylase-1 expression in the murine midbrain raphe

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2010.496448

Ovarian steroid regulation of monoamine oxidase-A and -B mRNAs in the macaque dorsal raphe and hypothalamic nuclei

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2010.496448

Selective serotonin reuptake inhibitors (SSRIs) and suicide in adults: meta-analysis of drug company data from placebo controlled, randomised controlled trials submitted to the MHRA's safety review

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2010.496448

Influence of gender and oral contraceptives on CYP2D6 and CYP2C19 activity in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2010.496448

Fluoxetine toxicity in a breastfed infant

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2010.496448

Gender effects in pharmacokinetics and pharmacodynamics

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2010.496448

Transplacental transfer of amitriptyline and nortriptyline in isolated perfused human placenta

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2010.496448

Placental passage of antidepressant medications

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2010.496448

Treatment of depression with atypical features: a meta-analytic approach

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2010.496448

Are gender differences important for the clinical effects of antidepressants?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2010.496448

Estrogen selectively increases tryptophan hydroxylase-2 mRNA expression in distinct subregions of rat midbrain raphe nucleus: association between gene expression and anxiety behavior in the open field

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2010.496448

Codependence of growth hormone-responsive, sexually dimorphic hepatic gene expression on signal transducer and activator of transcription 5b and hepatic nuclear factor 4alpha.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2010.496448

Generalized anxiety disorder in women

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2010.496448

Effect of age and gender on the activity of human hepatic CYP3A

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2010.496448

Progesterone-estrogen effects on uptake and release of norepinephrine by synaptosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2010.496448

Patterns and predictors of remission, response and recovery in major depression treated with fluoxetine or nortriptyline

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2010.496448

Maternal use of selective serotonin re-uptake inhibitors and persistent pulmonary hypertension of the newborn

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2010.496448

Excretion of doxepin and N-desmethyldoxepin in human milk

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2010.496448

Sex differences in antidepressant response in recent antidepressant clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2010.496448

BMI, sex, and antidepressant response.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2010.496448

Up-regulation of tryptophan hydroxylase expression and serotonin synthesis by sertraline

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2010.496448

Overweight and obesity affect treatment response in major depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2010.496448

Gender differences in treatment response to sertraline versus imipramine in chronic depression

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2010.496448

Severe adverse effects in a newborn with two defective CYP2D6 alleles after exposure to paroxetine during late pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2010.496448

Possible association between fluoxetine hydrochloride and colic in an infant.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2010.496448

Presence of depressive symptoms during early pregnancy and the risk of preterm delivery: a prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2010.496448

Antidepressants in amniotic fluid: another route of fetal exposure.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2010.496448

Placental passage of tricyclic antidepressants

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2010.496448

First-trimester use of selective serotonin-reuptake inhibitors and the risk of birth defects

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2010.496448

Ovarian steroid regulation of serotonin reuptake transporter (SERT) binding, distribution, and function in female macaques

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2010.496448

Effect of gonadal steroids on activities of monoamine oxidase and choline acetylase in rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2010.496448

Depressive symptoms among pregnant women screened in obstetrics settings

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2010.496448

Gender differences in depression: findings from the STAR*D study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2010.496448

Gender differences in the efficacy of fluoxetine and maprotiline in depressed patients: a double-blind trial of antidepressants with serotonergic or norepinephrinergic reuptake inhibition profile

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2010.496448

Depression with atypical features in the National Comorbidity Survey: classification, description, and consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2010.496448

Are selective serotonin reuptake inhibitors cardiac teratogens? Echocardiographic screening of newborns with persistent heart murmur

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2010.496448

Plasma Levels of Imipramine and Desmethylimipramine during Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2010.496448

Neonatal signs after late in utero exposure to serotonin reuptake inhibitors: literature review and implications for clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2010.496448

Short-term combinational therapy of low-dose estrogen with selective serotonin re-uptake inhibitor (fluvoxamine) for oophorectomized women with hot flashes and depressive tendencies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2010.496448

Anxious depression and response to treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2010.496448

Differences between males and females in rates of serotonin synthesis in human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2010.496448

The dopamine transporter and cytochrome P45OIID1 (debrisoquine 4-hydroxylase) in brain: resolution and identification of two distinct [3H]GBR-12935 binding proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2010.496448

Child development following exposure to tricyclic antidepressants or fluoxetine throughout fetal life: a prospective, controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2010.496448

Neonatal outcomes after prenatal exposure to selective serotonin reuptake inhibitor antidepressants and maternal depression using population-based linked health data

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2010.496448

Acute 17 beta-estradiol treatment down-regulates serotonin 5HT1A receptor mRNA expression in the limbic system of female rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2010.496448

Phenotypic polymorphism and gender-related differences of CYP1A2 activity in a Chinese population

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2010.496448

Effectiveness of antidepressant treatments in pre-menopausal versus post-menopausal women: a pilot study on differential effects of sex hormones on antidepressant effects

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2010.496448

Obesity among outpatients with major depressive disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2010.496448

Gender differences in response to differing antidepressant drug classes: two negative studies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2010.496448

Antidepressant use in the postpartum period: practical considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2010.496448

Symptoms of atypical depression

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2010.496448

Gender differences in treatment response

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2010.496448

Are there differences between women's and men's antidepressant responses?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2010.496448

Transfer of escitalopram and its metabolite demethylescitalopram into breastmilk

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2010.496448

The clinical nature and formal diagnosis of premenstrual, postpartum, and perimenopausal affective disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2010.496448

Is therapeutic drug monitoring a case for optimizing clinical outcome and avoiding interactions of the selective serotonin reuptake inhibitors?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2010.496448

Therapeutic drug monitoring of racemic citalopram: a 5-year experience in Sweden, 1992-1997.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2010.496448

Acute treatment with the antidepressant fluoxetine internalizes 5-HT1A autoreceptors and reduces the in vivo binding of the PET radioligand [18F]MPPF in the nucleus raphe dorsalis of rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2010.496448

Chronic administration of venlafaxine fails to attenuate 5-HT1A receptor function at the level of receptor-G protein interaction.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2010.496448

5-HT(1A) receptor function in major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2010.496448

Gender difference in ifosfamide metabolism by human liver microsomes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2010.496448

Psychiatric illness and adverse pregnancy outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2010.496448

Important messages in the 'post': recent discoveries in 5-HT neurone feedback control

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2010.496448

The onset of postpartum depression: Implications for clinical screening in obstetrical and primary care.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2010.496448

Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2010.496448

Differential efficacy of escitalopram and nortriptyline on dimensional measures of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2010.496448

Body weight as a predictor of antidepressant efficacy in the GENDEP project

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2010.496448

Differential enhancement of antidepressant penetration into the brain in mice with abcb1ab (mdr1ab) P-Glycoprotein gene disruption

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2010.496448

Comprehensive survey of the relationship between serum concentration and therapeutic effect of amitriptyline in depression

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2010.496448

Pooled analysis of antidepressant levels in lactating mothers, breast milk, and nursing infants

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2010.496448

Maternal use of selective serotonin reuptake inhibitors and risk of congenital malformations.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2010.496448

Sex is a major determinant of CYP3A4 expression in human liver

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2010.496448

Phenomenology and course of generalised anxiety disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2010.496448

Sex, trauma, stress hormones and depression

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2010.496448

Response to SSRIs and role of the hormonal therapy in post-menopausal depression

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2010.496448

10.3109/09540261.2010.496448

21 January 2018

Identifiers

DOI

1 reference

23 August 2017

1 reference

PubMed ID

21047161